Robert D. Budens

Array ( [id] => 3794722 [patent_doc_number] => 05726292 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Immuno-potentiating systems for preparation of immunogenic materials' [patent_app_type] => 1 [patent_app_number] => 8/143365 [patent_app_country] => US [patent_app_date] => 1993-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10736 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726292.pdf [firstpage_image] =>[orig_patent_app_number] => 143365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3569040 [patent_doc_number] => 05484907 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => 'Nucleotides coding for the extracellular membrane-bound segment of IgA' [patent_app_type] => 1 [patent_app_number] => 8/140721 [patent_app_country] => US [patent_app_date] => 1993-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7184 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484907.pdf [firstpage_image] =>[orig_patent_app_number] => 140721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3564559 [patent_doc_number] => 05482858 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-09 [patent_title] => 'Polypeptide linkers for production of biosynthetic proteins' [patent_app_type] => 1 [patent_app_number] => 8/139171 [patent_app_country] => US [patent_app_date] => 1993-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 58 [patent_no_of_words] => 16042 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/482/05482858.pdf [firstpage_image] =>[orig_patent_app_number] => 139171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3471889 [patent_doc_number] => 05476786 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'Biosynthetic antibody binding sites' [patent_app_type] => 1 [patent_app_number] => 8/139901 [patent_app_country] => US [patent_app_date] => 1993-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 25 [patent_no_of_words] => 10421 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476786.pdf [firstpage_image] =>[orig_patent_app_number] => 139901 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857624 [patent_doc_number] => 05792620 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Cloning and expression of human islet glutamic acid decarboxylase autoantigen' [patent_app_type] => 1 [patent_app_number] => 8/108145 [patent_app_country] => US [patent_app_date] => 1993-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12524 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792620.pdf [firstpage_image] =>[orig_patent_app_number] => 108145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890248 [patent_doc_number] => 05834429 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Small peptides which inhibit binding to T-4 receptors and act as immunogens' [patent_app_type] => 1 [patent_app_number] => 8/105926 [patent_app_country] => US [patent_app_date] => 1993-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4665 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834429.pdf [firstpage_image] =>[orig_patent_app_number] => 105926 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2993408 [patent_doc_number] => 05362643 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-11-08 [patent_title] => 'Antibodies to epitopes present on membrane-bound but not secreted IGA' [patent_app_type] => 1 [patent_app_number] => 8/095068 [patent_app_country] => US [patent_app_date] => 1993-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7171 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/362/05362643.pdf [firstpage_image] =>[orig_patent_app_number] => 095068 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4209908 [patent_doc_number] => 06086880 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Rotavirus peptide compositions and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/089397 [patent_app_country] => US [patent_app_date] => 1993-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16893 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/086/06086880.pdf [firstpage_image] =>[orig_patent_app_number] => 089397 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889582 [patent_doc_number] => 05750106 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'Human monoclonal antibodies to cytomegalovirus' [patent_app_type] => 1 [patent_app_number] => 8/082623 [patent_app_country] => US [patent_app_date] => 1993-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5934 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750106.pdf [firstpage_image] =>[orig_patent_app_number] => 082623 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3591862 [patent_doc_number] => 05487974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-30 [patent_title] => 'Method for detecting complexes containing human leukocyte antigen A2 (HLA-A2) molecules and a tyrosinase drived peptide on abnormal cells' [patent_app_type] => 1 [patent_app_number] => 8/081673 [patent_app_country] => US [patent_app_date] => 1993-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 5655 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/487/05487974.pdf [firstpage_image] =>[orig_patent_app_number] => 081673 [rel_patent_id] =>[rel_patent_doc_number] =>)